Log In Sign up
The largest database of trusted experimental protocols
Protocol detail

Pharmacovigilance Analysis of Anti-HER2 Therapy ADRs

Protocol full text hidden due to copyright restrictions

However, the full text is available at the following link: Access Free Full Text.

Waliany S., Caswell-Jin J., Riaz F., Myall N., Zhu H., Witteles R.M, & Neal J.W. (2023). Pharmacovigilance Analysis of Heart Failure Associated With Anti-HER2 Monotherapies and Combination Regimens for Cancer. JACC: CardioOncology, 5(1), 85-98.
Publication 2023
Adverse drug reactions Afatinib Cancer drug Capecitabine Chemotherapy Dacomitinib Disability Drug Health care professionals Her2 Hospitalization Institutional review board Lapatinib Malignancy Margetuximab Mobocertinib Monoclonal antibodies Neratinib Patient Pertuzumab Poziotinib Pyrotinib Regimens T dm1 Trastuzumab Tucatinib

Corresponding Organization : Palo Alto Institute

Other organizations : Cardiovascular Institute of the South

Protocol comparator
Top 5 similar protocols

Sign up for free or view similar protocols

Variable analysis

Dependent Variables detection not available due to copyright restrictions.
Unable to provide accurate variables.

Annotations

Annotations not available due to copyright restrictions

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!